Paper3908514
Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids).
Bamford JT and 2 others. J Am Acad Dermatol, 1985. Cited by 93 papers, by iCite.
Cite this record
ConductScience Library. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids). Papers, record 3908514. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3908514
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dermatitis, Atopic | Major topic |
| Dermatologic Agents | Major topic |
| Fatty Acids, Essential | Major topic |
| Fatty Acids, Unsaturated | Major topic |
| Administration, Oral | |
| Adolescent | |
| Adult | |
| Aged | |
| Child | |
| Child, Preschool | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Humans | |
| Linoleic Acids | |
| Middle Aged | |
| Oenothera biennis | |
| Plant Oils | |
| Random Allocation | |
| gamma-Linolenic Acid |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38360611 | The effect of Oenothera biennis (Evening primrose) oil on inflammatory diseases: a systematic review of clinical trials. | BMC Complement Med Ther | 2024 | https://conductscience.org/library/papers/38360611 | PubMed |
| 34200727 | A Systematic Review and Meta-Analysis of the Efficacy of Evening Primrose Oil for Mastalgia Treatment. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/34200727 | PubMed |
| 30402601 | Complementary and alternative medicine (CAM) and atopic eczema. | Allergol Select | 2017 | https://conductscience.org/library/papers/30402601 | PubMed |
| 30065580 | Effect of Evening Primrose Oil on Korean Patients With Mild Atopic Dermatitis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Study. | Ann Dermatol | 2018 | https://conductscience.org/library/papers/30065580 | PubMed |
| 28861804 | Therapeutic Benefits of Natural Ingredients for Atopic Dermatitis. | Chin J Integr Med | 2018 | https://conductscience.org/library/papers/28861804 | PubMed |
| 25264237 | Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. | J Am Acad Dermatol | 2014 | https://conductscience.org/library/papers/25264237 | PubMed |
| 24003269 | Dose-dependent effects of evening primrose oil in children and adolescents with atopic dermatitis. | Ann Dermatol | 2013 | https://conductscience.org/library/papers/24003269 | PubMed |
| 23633319 | Oral evening primrose oil and borage oil for eczema. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23633319 | PubMed |
| 18750675 | Diet and atopic dermatitis. | West J Med | 1989 | https://conductscience.org/library/papers/18750675 | PubMed |
| 18163227 | Treatment of eczema. | Clin Rev Allergy Immunol | 2007 | https://conductscience.org/library/papers/18163227 | PubMed |
| 14670885 | Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial. | BMJ | 2003 | https://conductscience.org/library/papers/14670885 | PubMed |
| 14670851 | Evening primrose oil for atopic dermatitis. | BMJ | 2003 | https://conductscience.org/library/papers/14670851 | PubMed |
| 9014601 | Epogam evening primrose oil treatment in atopic dermatitis and asthma. | Arch Dis Child | 1996 | https://conductscience.org/library/papers/9014601 | PubMed |
| 7950599 | Evening primrose oil. | BMJ | 1994 | https://conductscience.org/library/papers/7950599 | PubMed |
| 7819863 | Evening primrose oil. Does not show promise in atopic dermatitis. | BMJ | 1994 | https://conductscience.org/library/papers/7819863 | PubMed |
| 7711624 | Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London. | BMJ | 1995 | https://conductscience.org/library/papers/7711624 | PubMed |
| 3147017 | Role of diet in treating atopic eczema: dietary manipulation has no value. | BMJ | 1988 | https://conductscience.org/library/papers/3147017 | PubMed |
| 2066937 | Recent developments in the treatment of childhood atopic eczema. | J R Coll Physicians Lond | 1991 | https://conductscience.org/library/papers/2066937 | PubMed |
| 1943500 | Supplementation with evening primrose oil in atopic dermatitis: effect on fatty acids in neutrophils and epidermis. | Lipids | 1991 | https://conductscience.org/library/papers/1943500 | PubMed |
| 1920221 | Atopic eczema. | J R Coll Physicians Lond | 1991 | https://conductscience.org/library/papers/1920221 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3908514
GET https://conductscience.org/api/papers/v1/3908514/cited_by?page=2